Results 251 to 260 of about 139,045 (309)
Azanucleoside treatment leads to B-cell precursor acute lymphoblastic leukemia. [PDF]
Blood NeoplasiaNegi V +8 more
europepmc +1 more source
Adverse reactions of dasatinib in pediatric acute lymphoblastic leukemia: a retrospective comparative cohort study. [PDF]
Transl PediatrYu LT +5 more
europepmc +1 more source
An explainable deep learning-based feature fusion model for acute lymphoblastic leukemia diagnosis and severity assessment. [PDF]
Front Med (Lausanne)Khan H +6 more
europepmc +1 more source
Detection of minimal residual disease in acute lymphoblastic leukemia
, 2005 Matteo Giovanni Della Porta +1 more
openalex +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hematology, 2002
AbstractThis is a comprehensive overview on the most recent developments in diagnosis and treatment of acute lymphoblastic leukemia (ALL).Dr. Dieter Hoelzer and colleagues give an overview of current chemotherapy approaches, prognostic factors, risk stratification, and new treatment options such as tyrosine kinase inhibitors and monoclonal antibodies ...
Dieter, Hoelzer +7 more
openaire +4 more sources
AbstractThis is a comprehensive overview on the most recent developments in diagnosis and treatment of acute lymphoblastic leukemia (ALL).Dr. Dieter Hoelzer and colleagues give an overview of current chemotherapy approaches, prognostic factors, risk stratification, and new treatment options such as tyrosine kinase inhibitors and monoclonal antibodies ...
Dieter, Hoelzer +7 more
openaire +4 more sources
2007
Acute lymphoblastic leukemia (ALL) comprises a heterogeneous group of disorders which originate from various important genetic lesions in B and T progenitor cells, including mutations that lead to stage-specific developmental arrest and those that impart the capacity for unlimited self-renewal, resulting in clonal expansion of immature progenitor cells
Biondi A., Scrideli C. A., Cazzaniga G.
+5 more sources
Acute lymphoblastic leukemia (ALL) comprises a heterogeneous group of disorders which originate from various important genetic lesions in B and T progenitor cells, including mutations that lead to stage-specific developmental arrest and those that impart the capacity for unlimited self-renewal, resulting in clonal expansion of immature progenitor cells
Biondi A., Scrideli C. A., Cazzaniga G.
+5 more sources
Pediatric Clinics of North America, 1997
Advances in the molecular and immunologic characterization of leukemic cells have greatly aided the diagnosis and risk assignment of ALL, as well as the monitoring of bone marrow samples for minimal residual disease. Currently, 75% of childhood cases have biologically and therapeutically relevant genetic abnormalities.
openaire +3 more sources
Advances in the molecular and immunologic characterization of leukemic cells have greatly aided the diagnosis and risk assignment of ALL, as well as the monitoring of bone marrow samples for minimal residual disease. Currently, 75% of childhood cases have biologically and therapeutically relevant genetic abnormalities.
openaire +3 more sources